About Viome
Viome is a company based in Los Alamos (United States) founded in 2016. Viome has raised $301.57 million across 8 funding rounds from investors including Khosla Ventures, Glico Group and Bold Capital Partners. Viome has completed 2 acquisitions, including Habit and Naring Health. Viome offers products and services including Full Body Intelligence™ Test, Gut Intelligence™ Test, Oral Health Intelligence™ Test, Personalized Supplements, and CancerDetect® Oral & Throat Test. Viome operates in a competitive market with competitors including Everlywell, Color, Invitae, Counsyl and Variant Bio, among others.
- Headquarter Los Alamos, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Viome Life Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$301.57 M (USD)
in 8 rounds
-
Latest Funding Round
$25 M (USD), Series D
Sep 09, 2024
-
Investors
Khosla Ventures
& 8 more
-
Employee Count
Not available
-
Investments & Acquisitions
Habit
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viome
Viome offers a comprehensive portfolio of products and services, including Full Body Intelligence™ Test, Gut Intelligence™ Test, Oral Health Intelligence™ Test, Personalized Supplements, and CancerDetect® Oral & Throat Test.
Analyzes microbiome for health conditions and biological age.
Identifies gut imbalances and inflammation for digestive health.
Assesses oral microbiome to improve teeth and gum health.
Custom formulas based on test results for targeted health support.
Screens for oral health risks and related conditions.
People of Viome
Unlock access to complete
Unlock access to complete
Funding Insights of Viome
Viome has successfully raised a total of $301.57M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $25 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Viome
Viome has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Khosla Ventures, Glico Group and Bold Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Investments are focused across multiple sectors by the firm.
|
Locked | Locked | Locked |
Investor details for Viome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viome
Viome has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Habit and Naring Health.
Investment portfolio details for Viome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Digtial health and precision nutriton program to manage chronic disease
|
Locked | Locked | 2022 | Locked | |
|
Personalized nutrition is delivered via DNA testing and meal services.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Viome
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Viome
Detailed financials for Viome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viome Comparisons
Peer comparison for Viome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viome
Viome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Color, Invitae, Counsyl and Variant Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
Personalized therapeutics are developed using genomic data for rare diseases.
|
Detailed competitors of Viome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viome
Complete news archive for Viome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viome
Viome was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Viome is headquartered in Los Alamos, United States. It is registered at Los Alamos, New Mexico, United States.
Viome is a funded company, having raised a total of $301.57M across 8 funding rounds to date.
Founded in 2016 and headquartered in Los Alamos, United States, bioinformatics solutions powered by machine learning are developed in the health technology sector. User data is analyzed to generate insights on health and well-being. Recommendations for dietary and behavioral adjustments are derived to support improved lifestyles. A Gut Intelligence kit is supplied for microbiome analysis in the gut.
Viome's top competitors include Variant Bio, Newtopia and Invitae.
Viome offers Full Body Intelligence™ Test, Gut Intelligence™ Test, Oral Health Intelligence™ Test, Personalized Supplements, and CancerDetect® Oral & Throat Test.
Viome has made 2 acquisitions, including Habit, and Naring Health.
Viome has 9 investors. Key investors include Khosla Ventures, Glico Group, Bold Capital Partners, Marc Benioff, and WestRiver Group.